Eads & Heald Wealth Management Danaher Corp Transaction History

Eads & Heald Wealth Management

  • $211 Million
  • Q3 2024

A detailed history of Eads & Heald Wealth Management transactions in Danaher Corp stock. As of the latest transaction made, Eads & Heald Wealth Management holds 7,918 shares of DHR stock, worth $1.87 Million. This represents 1.04% of its overall portfolio holdings.

Number of Shares
7,918
Previous 8,385 5.57%
Holding current value
$1.87 Million
Previous $2.09 Million 5.11%
% of portfolio
1.04%
Previous 1.02%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 28, 2024
SELL
$239.25 - $280.76 $111,729 - $131,114
-467 Reduced 5.57%
7,918 $2.2 Million
Q2 2024

Jul 23, 2024
SELL
$235.51 - $267.98 $37,681 - $42,876
-160 Reduced 1.87%
8,385 $2.09 Million
Q1 2024

Apr 23, 2024
SELL
$224.58 - $256.19 $113,188 - $129,119
-504 Reduced 5.57%
8,545 $2.13 Million
Q4 2023

Jan 30, 2024
SELL
$185.1 - $233.13 $14,993 - $18,883
-81 Reduced 0.89%
9,049 $2.09 Million
Q3 2023

Oct 27, 2023
SELL
$233.08 - $265.59 $44,052 - $50,196
-189 Reduced 2.03%
9,130 $2.27 Million
Q2 2023

Jul 25, 2023
SELL
$224.99 - $256.14 $45,447 - $51,740
-202 Reduced 2.12%
9,319 $2.24 Million
Q1 2023

Apr 21, 2023
SELL
$239.75 - $277.0 $41,716 - $48,198
-174 Reduced 1.79%
9,521 $2.4 Million
Q4 2022

Jan 27, 2023
BUY
$241.42 - $282.29 $97,533 - $114,045
404 Added 4.35%
9,695 $2.57 Million
Q3 2022

Oct 27, 2022
SELL
$247.06 - $1507.4 $11,858 - $72,355
-48 Reduced 0.51%
9,291 $2.4 Million
Q2 2022

Jul 26, 2022
SELL
$237.11 - $299.66 $13,515 - $17,080
-57 Reduced 0.61%
9,339 $2.37 Million
Q1 2022

Apr 27, 2022
SELL
$257.27 - $315.76 $52,225 - $64,099
-203 Reduced 2.11%
9,396 $2.76 Million
Q4 2021

Jan 31, 2022
SELL
$292.08 - $329.01 $17,524 - $19,740
-60 Reduced 0.62%
9,599 $3.16 Million
Q3 2021

Oct 27, 2021
SELL
$272.21 - $332.43 $577,085 - $704,751
-2,120 Reduced 18.0%
9,659 $2.94 Million
Q2 2021

Jul 30, 2021
SELL
$225.08 - $271.69 $75,851 - $91,559
-337 Reduced 2.78%
11,779 $3.16 Million
Q1 2021

Apr 29, 2021
SELL
$212.38 - $245.9 $97,907 - $113,359
-461 Reduced 3.67%
12,116 $2.73 Million
Q4 2020

Feb 02, 2021
SELL
$212.5 - $245.46 $177,862 - $205,450
-837 Reduced 6.24%
12,577 $2.79 Million
Q3 2020

Nov 02, 2020
SELL
$177.16 - $215.33 $429,613 - $522,175
-2,425 Reduced 15.31%
13,414 $2.89 Million
Q2 2020

Jul 29, 2020
SELL
$128.7 - $176.83 $127,541 - $175,238
-991 Reduced 5.89%
15,839 $2.8 Million
Q1 2020

May 01, 2020
SELL
$121.39 - $169.05 $136,320 - $189,843
-1,123 Reduced 6.26%
16,830 $2.33 Million
Q4 2019

Jan 31, 2020
SELL
$133.47 - $153.48 $25,893 - $29,775
-194 Reduced 1.07%
17,953 $2.76 Million
Q3 2019

Oct 31, 2019
SELL
$135.4 - $146.47 $46,036 - $49,799
-340 Reduced 1.84%
18,147 $2.62 Million
Q2 2019

Jul 30, 2019
SELL
$124.88 - $143.73 $71,431 - $82,213
-572 Reduced 3.0%
18,487 $0
Q1 2019

Apr 26, 2019
SELL
$97.62 - $132.29 $116,265 - $157,557
-1,191 Reduced 5.88%
19,059 $0
Q4 2018

Jan 31, 2019
SELL
$94.85 - $109.54 $26,652 - $30,780
-281 Reduced 1.37%
20,250 $2.09 Million
Q3 2018

Oct 31, 2018
SELL
$98.13 - $108.9 $9,420 - $10,454
-96 Reduced 0.47%
20,531 $0
Q2 2018

Jul 27, 2018
BUY
$96.1 - $103.24 $15,376 - $16,518
160 Added 0.78%
20,627 $0
Q1 2018

Apr 26, 2018
SELL
$92.16 - $103.8 $58,152 - $65,497
-631 Reduced 2.99%
20,467 $0
Q4 2017

Jan 31, 2018
BUY
$85.26 - $94.62 $2,728 - $3,027
32 Added 0.15%
21,098 $0
Q3 2017

Oct 27, 2017
BUY
$79.29 - $88.45 $1.67 Million - $1.86 Million
21,066
21,066 $0

Others Institutions Holding DHR

# of Institutions
2,508
Shares Held
542M
Call Options Held
7.07M
Put Options Held
4.55M
View Full List

About DANAHER CORP

DHR Quotes by TradingView
  • Ticker DHR
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 727,963,008
  • Market Cap $172B
  • Description
  • Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...
More about DHR
Track This Portfolio

Track Eads & Heald Wealth Management Portfolio

Follow Eads & Heald Wealth Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eads & Heald Wealth Management, based on Form 13F filings with the SEC.

News

Stay updated on Eads & Heald Wealth Management with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email